PD-L1/PD-1 Cancer Immunotherapy and New Targets
Gordon Freeman, PhD. Professor of Medicine, Harvard Medical School Host: Patrick Hogan
Gordon Freeman, PhD. Professor of Medicine, Harvard Medical School Host: Patrick Hogan
Honbo Chi, Pd.D. 5-11-22 at La Jolla Institute for Immunology.
Ping-Chih Ho 4-22-2022 at La Jolla Institute for Immunology.
Annie Elong Ngono, Ph.D., is an infectious disease specialist at La Jolla Institute for Immunology, where she works to find
San Diego high school student Jeffrey Wang spearheads LJI research project, receiving national recognition as Regeneron Science Talent Search finalist.
Hear from Deputy Director of Advancement Kelsey Dale about the La Jolla Institute’s Tullie and Rickey Families SPARK Awards program.
With scattered reports of recovered COVID-19 patients testing positive again, a lot of people are wondering if it’s possible to
The outbreak of the novel coronavirus has the world in its grip. Not since the Spanish flue outbreak of 1918
On April 6, 2020, infectious disease expert Erica Ollmann Saphire, Ph.D. shared her research efforts and observations from the field
Rana Herro, Ph.D., 2017 SPARK finalist, is proving the power of philanthropy and SPARK. Not only did she potentially discover
Spotting cancers earlier could save millions of lives every year but most of the currently used cancer screening tests fail
In type 1 diabetes (T1D) the body’s own immune system attacks and destroys the insulin-producing beta cells in the pancreas.